Similar articles for PMID: 30737300

Year	Number of Results
2004	1
2007	1
2010	1
2012	1
2014	1
2015	10
2016	16
2017	22
2018	24
2019	27
2020	26
2021	22
2022	17
2023	3
2024	0

1

First Clinicopathologic Evidence of a Non-PSMA-Related Uptake Mechanism for ⁶⁸Ga-PSMA-11 in Salivary Glands.

Rupp NJ, Umbricht CA, Pizzuto DA, Lenggenhager D, Töpfer A, Müller J, Muehlematter UJ, Ferraro DA, Messerli M, Morand GB, Huber GF, Eberli D, Schibli R, Müller C, Burger IA. Rupp NJ, et al. J Nucl Med. 2019 Sep;60(9):1270-1276. doi: 10.2967/jnumed.118.222307. Epub 2019 Feb 8. J Nucl Med. 2019. PMID: 30737300 Free article.

2

More advantages in detecting bone and soft tissue metastases from prostate cancer using ¹⁸F-PSMA PET/CT.

Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Pianou NK, et al. Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. Hell J Nucl Med. 2019. PMID: 30843003 Free article.

3

The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions.

Afshar-Oromieh A, Hetzheim H, Kratochwil C, Benesova M, Eder M, Neels OC, Eisenhut M, Kübler W, Holland-Letz T, Giesel FL, Mier W, Kopka K, Haberkorn U. Afshar-Oromieh A, et al. J Nucl Med. 2015 Nov;56(11):1697-705. doi: 10.2967/jnumed.115.161299. Epub 2015 Aug 20. J Nucl Med. 2015. PMID: 26294298 Free article.

4

Immunohistochemical Validation of PSMA Expression Measured by ⁶⁸Ga-PSMA PET/CT in Primary Prostate Cancer.

Woythal N, Arsenic R, Kempkensteffen C, Miller K, Janssen JC, Huang K, Makowski MR, Brenner W, Prasad V. Woythal N, et al. J Nucl Med. 2018 Feb;59(2):238-243. doi: 10.2967/jnumed.117.195172. Epub 2017 Aug 3. J Nucl Med. 2018. PMID: 28775203 Free article.

5

What a difference a methylene makes: replacing Glu with Asp or Aad in the Lys-urea-Glu pharmacophore of PSMA-targeting radioligands to reduce kidney and salivary gland uptake.

Kuo HT, Lin KS, Zhang Z, Zhang C, Merkens H, Tan R, Roxin A, Uribe CF, Bénard F. Kuo HT, et al. Theranostics. 2022 Aug 21;12(14):6179-6188. doi: 10.7150/thno.76571. eCollection 2022. Theranostics. 2022. PMID: 36168623 Free PMC article.

6

⁶⁸Ga-PSMA-HBED-CC PET/CT imaging for adenoid cystic carcinoma and salivary duct carcinoma: a phase 2 imaging study.

van Boxtel W, Lütje S, van Engen-van Grunsven ICH, Verhaegh GW, Schalken JA, Jonker MA, Nagarajah J, Gotthardt M, van Herpen CML. van Boxtel W, et al. Theranostics. 2020 Jan 12;10(5):2273-2283. doi: 10.7150/thno.38501. eCollection 2020. Theranostics. 2020. PMID: 32089741 Free PMC article. Clinical Trial.

7

A comparative study of peptide-based imaging agents [⁶⁸Ga]Ga-PSMA-11, [⁶⁸Ga]Ga-AMBA, [⁶⁸Ga]Ga-NODAGA-RGD and [⁶⁸Ga]Ga-DOTA-NT-20.3 in preclinical prostate tumour models.

Zhang-Yin J, Provost C, Cancel-Tassin G, Rusu T, Penent M, Radulescu C, Comperat E, Cussenot O, Montravers F, Renard-Penna R, Talbot JN, Prignon A. Zhang-Yin J, et al. Nucl Med Biol. 2020 May-Jun;84-85:88-95. doi: 10.1016/j.nucmedbio.2020.03.005. Epub 2020 Mar 30. Nucl Med Biol. 2020. PMID: 32251995 Free article.

8

Comparison of Prostate-Specific Membrane Antigen Expression Levels in Human Salivary Glands to Non-Human Primates and Rodents.

Roy J, Warner BM, Basuli F, Zhang X, Wong K, Pranzatelli T, Ton AT, Chiorini JA, Choyke PL, Lin FI, Jagoda EM. Roy J, et al. Cancer Biother Radiopharm. 2020 May;35(4):284-291. doi: 10.1089/cbr.2019.3079. Epub 2020 Feb 19. Cancer Biother Radiopharm. 2020. PMID: 32074455 Free PMC article.

9

Cold Kit for Prostate-Specific Membrane Antigen (PSMA) PET Imaging: Phase 1 Study of ⁶⁸Ga-Tris(Hydroxypyridinone)-PSMA PET/CT in Patients with Prostate Cancer.

Hofman MS, Eu P, Jackson P, Hong E, Binns D, Iravani A, Murphy D, Mitchell C, Siva S, Hicks RJ, Young JD, Blower PJ, Mullen GE. Hofman MS, et al. J Nucl Med. 2018 Apr;59(4):625-631. doi: 10.2967/jnumed.117.199554. Epub 2017 Oct 6. J Nucl Med. 2018. PMID: 28986512 Free PMC article. Clinical Trial.

10

Physiological PSMA Uptake in the Tubarial Salivary Glands and Its Implications in the PARIS Protocol-A First Study of Its Kind!

Sakthivel P, Thakar A, Arunraj ST, Prashanth A, Kumar R, Sharma SC, Kumar R. Sakthivel P, et al. Clin Nucl Med. 2021 Aug 1;46(8):e398-e405. doi: 10.1097/RLU.0000000000003583. Clin Nucl Med. 2021. PMID: 33782285

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

142 results

Results by year